93 related articles for article (PubMed ID: 116049)
1. Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion.
Welsch CW; Brown CK; Goodrich-Smith M; Van J; Denenberg B; Anderson TM; Brooks CL
J Natl Cancer Inst; 1979 Nov; 63(5):1211-4. PubMed ID: 116049
[TBL] [Abstract][Full Text] [Related]
2. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
[TBL] [Abstract][Full Text] [Related]
4. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Sylvester PW; Ip C; Ip MM
Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
[TBL] [Abstract][Full Text] [Related]
5. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF
Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344
[TBL] [Abstract][Full Text] [Related]
6. Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine.
Sumi C; Yokoro K; Matsushima R
Cancer Res; 1983 Oct; 43(10):4781-5. PubMed ID: 6883334
[TBL] [Abstract][Full Text] [Related]
7. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
VanderPloeg LC; Wolfrom DM; Welsch CW
Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
[TBL] [Abstract][Full Text] [Related]
8. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of spontaneous mammary tumorigenesis by temporal inhibition of prolactin secretion in rats at young ages.
Nagasawa H; Morii S
Cancer Res; 1981 May; 41(5):1935-7. PubMed ID: 7214361
[TBL] [Abstract][Full Text] [Related]
10. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
11. Adrenal regulation of mammary tumorigenesis in female Sprague-Dawley rats: incidence, latency, and yield of mammary tumors.
Carter JH; Carter HW; Meade J
Cancer Res; 1988 Jul; 48(13):3801-7. PubMed ID: 3132320
[TBL] [Abstract][Full Text] [Related]
12. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
Sylvester PW; Aylsworth CF; Meites J
Cancer Res; 1981 Apr; 41(4):1384-8. PubMed ID: 6783295
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of growth of carcinogen-induced mammary cancers in rats by thyrotropin-releasing hormone.
Chen HJ; Bradley CJ; Meites J
Cancer Res; 1977 Jan; 37(1):64-6. PubMed ID: 401473
[TBL] [Abstract][Full Text] [Related]
14. Prolactin and the development and progression of early neoplastic mammary gland lesions.
Welsch CW
Cancer Res; 1978 Nov; 38(11 Pt 2):4054-8. PubMed ID: 698954
[TBL] [Abstract][Full Text] [Related]
15. 2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
Welsch CW; Goodrich-Smith M; Brown CK; Mackie D; Johnson D
Oncology; 1982; 39(2):88-92. PubMed ID: 6801566
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of early preneoplastic lesions of the mammary gland.
Welsch CW
Cancer Res; 1976 Jul; 36(7 PT 2):2621-5. PubMed ID: 1277169
[TBL] [Abstract][Full Text] [Related]
17. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
Rose DP; Noonan JJ
Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
[TBL] [Abstract][Full Text] [Related]
18. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
19. Retinoid feeding, hormone inhibition, and/or immune stimulation and the genesis of carcinogen-induced rat mammary carcinomas.
Welsch CW; DeHoog JV
Cancer Res; 1983 Feb; 43(2):585-91. PubMed ID: 6401220
[TBL] [Abstract][Full Text] [Related]
20. Influence of caffeine and/or coffee consumption on the initiation and promotion phases of 7,12-dimethylbenz(a)anthracene-induced rat mammary gland tumorigenesis.
Welsch CW; DeHoog JV; O'Connor DH
Cancer Res; 1988 Apr; 48(8):2068-73. PubMed ID: 3127044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
